G863-0235 Screening compound: 3-bromo-N-{[6-(4-fluorophenyl)-2H,3H-imidazo[2,1-b][1,3]thiazol-5-yl]methyl}benzamide

G863-0235 Screening compound: 3-bromo-N-{[6-(4-fluorophenyl)-2H,3H-imidazo[2,1-b][1,3]thiazol-5-yl]methyl}benzamide
G863-0235 Screening compound: 3-bromo-N-{[6-(4-fluorophenyl)-2H,3H-imidazo[2,1-b][1,3]thiazol-5-yl]methyl}benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G863-0235
3-bromo-N-{[6-(4-fluorophenyl)-2H,3H-imidazo[2,1-b][1,3]thiazol-5-yl]methyl}benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G863-0235

Molecular Formula

C19H15BrFN3OS (C19 H15 BrFN3 OS)

Compound Name

3-bromo-N-{[6-(4-fluorophenyl)-2H,3H-imidazo[2,1-b][1,3]thiazol-5-yl]methyl}benzamide

IUPAC name

3-bromo-N-{[6-(4-fluorophenyl)-2H3H-imidazo[21-b][13]thiazol-5-yl]methyl}benzamide

SMILES

O=C(c1cccc(Br)c1)NCc1c(-c(cc2)ccc2F)nc2SCCn12

InChI

InChI=1S/C19H15BrFN3OS/c20-14-3-1-2-13(10-14)18(25)22-11-16-17(12-4-6-15(21)7-5-12)23-19-24(16)8-9-26-19/h1-7,10H,8-9,11H2,(H,22,25)

InChI Key

IBJGLORUAOONAY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD09238992

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

432.32

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

4.434

Distribution Coefficient, logD

4.406

Water Solubility, LogSw

-4.36

Polar Surface Area

35.632

Acid Dissociation Constant (pKa)

10.20

Base Dissociation Constant (pKb)

6.22

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

15.80

G863-0235 in Drug Discovery

Included in Screening Libraries

Proline Kinase Library (2105 compounds)

Targeted Diversity Library (40567 compounds)

Indoleamine 2,3-dioxygenase 1 Focused Library (5816 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Nervous system
  • Male
  • Female
  • Endocrine
  • Cancer
  • Digestive system
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Immune system
  • Cancer
Targets:
  • Kinases
  • Others
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with G863-0235 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G863-0235?
Check Price and Availability of G863-0235, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G863-0235 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G863-0235
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G863-0235
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G863-0235 available by request